Nazanene H Esfandiari, MD
Clinical Professor of Internal Medicine
Service Chief
MEND and Program Director
Hospital Intensive Insulin Program
[email protected]

Available to mentor

Nazanene H Esfandiari, MD
Clinical Professor
  • About
  • Center Memberships
  • Recent Publications
  • About

    Nazanene H. Esfandiari, MD, is a Clinical Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes (MEND). Dr. Esfandiari received her medical degree from the University of Bordeaux in France, completed internal medicine residency in France and at UMASS Memorial Health Center in Massachusetts, and then completed fellowship in endocrinology at the University of Michigan. She joined the faculty at the University of Michigan in 2003. She was inducted into Clinical Excellence Society at the University of Michigan in 2014. She is the MEND Service Chief, Co-director of Hospital Intensive Insulin Program (HIIP) and Assistant Chief for the Inpatient Endocrine Consult.
    Dr. Esfandiari’s practice focuses on thyroid cancer, thyroid disorders, post bariatric care, and diabetes. She is also interested in medical education and is the Co-director of the Endocrine Sequence at the University of Michigan Medical School. In addition, Dr. Esfandiari has served in several national committees at the Endocrine Society and American Thyroid Association (ATA).

    Center Memberships
    • Center Member
      Caswell Diabetes Institute
    Recent Publications See All Publications
    • Journal Article
      Analytical Accuracy of a Continuous Glucose Monitor in Adult Diabetic Ketoacidosis
      Haas NL, Ang L, Esfandiari NH, Khan AM, Cranford JA, Cohen A, Sell J, Abdel-Hamid M, Romanchik KE, Korley FK. CHEST Critical Care, 2024 Nov; 100109 DOI:10.1016/j.chstcc.2024.100109
    • Journal Article
      5159 Bone Disease Related To PLS3 Gene Mutation
      Saberi S, Esfandiari NH. Journal of the Endocrine Society, 2024 Oct 5; 8 (Supplement_1): bvae163.367 DOI:10.1210/jendso/bvae163.367
    • Journal Article
      6722 Increase in Femoral Neck BMD After Parathyroidectomy in Patients with Mild Primary Hyperparathyroidism
      Kather FA, Clines GA, Janney C, Hughes DT, Esfandiari NH, Saberi S. Journal of the Endocrine Society, 2024 Oct 5; 8 (Supplement_1): bvae163.445 DOI:10.1210/jendso/bvae163.445
    • Journal Article
      1130-P: Enhancing Safety—Managing Individuals on SGLT-2 Inhibitors during the Perioperative Period
      ALIMATHUNISA ABDUL KATHER F, IYENGAR JJ, ESFANDIARI NH, BLANK R, SABERI S, KUMAR SS, GARCIA DJ, BUTLER S, JANKE EL, CIARKOWSKI SL, ANG L. Diabetes, 2024 Jun 14; 73 (Supplement_1): DOI:10.2337/db24-1130-p
    • Presentation
      Endocrine Emergency in the ICU, what is new?
      Esfandiari N. 2024 May 28;
    • Proceeding / Abstract / Poster
      #1704449 Double-Blinded versus Single-Blinded Peer Reviews in Endocrine Research: Does It Matter?
      Papaleontiou M, Hodish G, Wininger M, Moretti B, Chen D, Esfandiari N, Haymart M, Papaleontiou M. Endocrine Practice, 2024 May; 30 (5): S75 - S75. DOI:10.1016/j.eprac.2024.03.272
    • Proceeding / Abstract / Poster
      #1704449 Double-Blinded versus Single-Blinded Peer Reviews in Endocrine Research: Does It Matter?
      Papaleontiou M, Hodish G, Wininger M, Moretti B, Chen D, Esfandiari N, Haymart M, Papaleontiou M. Endocrine Practice, 2024 May; 30 (5): s75 DOI:10.1016/j.eprac.2024.03.272
    • Journal Article
      Cardiovascular Autonomic Neuropathy and Risk of Kidney Function Decline in Type 1 and Type 2 Diabetes: Findings From the PERL and ACCORD Cohorts.
      Tang Y, Ang L, Jaiswal M, Dillon BR, Esfandiari NH, Shah HS, Spino C, Plunkett C, Perkins BA, Pop-Busui R, Doria A. Diabetes, 2024 May 1; 73 (5): 751 - 762. DOI:10.2337/db23-0247
      PMID: 37467433